Aura Biosciences

Aura Biosciences

AURA· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -33.7% in FY2025

Elisabet de los Pinos, Ph.D. is the CEO of Aura Biosciences and was paid $4.0M in FY2025 (Dec), up 10%.

Pay$100 in the stock at the end of FY21 → $32
CEO pay is from each Aura Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Elisabet de los Pinos, Ph.D.FY2025
  2. 2Anthony GibneyFY2025
  3. 3J. Jill Hopkins, M.D.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Aura Biosciences paid its 3 named executives $8.9M in total in FY2025 (Dec). CEO Elisabet de los Pinos, Ph.D. was paid $4.0M of that.

Name
Elisabet de los Pinos, Ph.D.President, Chief Executive Officer and Director
Anthony GibneyChief Financial and Business OfficerNot disclosedNot disclosed
J. Jill Hopkins, M.D.Chief Medical Officer and President of Research and Development

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Aura Biosciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board1

See all
  • Antony MattessichDirector · 4 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 20, 2026FY2025
Annual report10-KMar 30, 2026FY2025
Proxy statementDEF 14AApr 24, 2025FY2024
Annual report10-KMar 24, 2025FY2024
Proxy statementDEF 14AApr 25, 2024FY2023
Annual report10-KMar 27, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data